Neogene Therapeutics, Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and manufacturing of next-generation T-cell receptor therapies (TCR-Ts), today announced it has entered into a definitive agreement to be acquired by AstraZeneca.
Bionano Genomics, Inc. (NASDAQ:BNGO) today announced that it has entered into a definitive agreement to acquire Purigen Biosystems, Inc. (Purigen), a company that develops and commercializes automated nucleic
USANA Health Sciences, Inc. (NYSE:USNA) today announced the acquisition of two companies—Rise Bar and Oola.
These emerging companies share USANA's health and wellness focus while offering distinct channels or
Third quarter earnings season is slowly wrapping up and analysts are tweaking their ratings accordingly.
Cantor Fitzgerald analyst Pablo Zuanic kicked off the week by taking a closer look at two cannabis stocks.